参考文献/References:
[1]Clarke W,Silverman BC,Zhang Z,et al.Characterization of renal allograft rejection by urinary proteomic analysis[J].Ann Surg,2003,237(5):660-664.
[2]Griffin SP,Nelson JE.Impact of a Clinical Solid Organ Transplant Pharmacist on Tacrolimus Nephrotoxicity,Therapeutic Drug Monitoring,and Institutional Revenue Generation in Adult Kidney Transplant Recipients[J].Prog Transplant,2016,26(4):314-321.
[3]Akhtar T,Sheikh N,Shan T,et al.Tacrolimus induced nephrotoxicity and pulmonary toxicity in Wistar rats[J].J BiolRegulHomeost Agents,2017,31(4):1061-1066.
[4]Pinana JL,Perez-Pitarch A,Garcia-Cadenas I,et al.A Time-to-Event Model for Acute Kidney Injury after Reduced-Intensity Conditioning Stem Cell Transplantation Using a Tacrolimus-and Sirolimus-based Graft-versus-Host Disease Prophylaxis[J].Biol Blood Marrow Transplant,2017,23(7):1177-1185.
[5]Souto-Rodríguez R,Molina-Pérez E,Castroagudín JF,et al.Differences in the incidence and clinical evolution of early neurotoxicity after liver transplantation based on tacrolimus formulation used in the immunosuppressive induction protocol[J].Transplant Proc,2014,46(9):3117-3120.
[6]Alagoz S,Gulcicek S,Oruc M,et al.Gangliocytoma Presenting With Tacrolimus Neurotoxicity in a Renal Transplant Recipient:Case Report[J].Transplant Proc,2016,48(9):3142-3144.
[7]Peddi VR,Wiseman A,Chavin K,et al.Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation[J].Transplant Rev(Orlando),2013,27(4):97-107.
[8]Xue W,Zhang Q,Xu Y,et al.Effects of tacrolimus and cyclosporine treatment on metabolic syndrome and cardiovascular risk factors after renal transplantation:a meta-analysis[J].Chin Med J,2014,127(12):2376-2381.
[9]Veroux M,Grosso G,Ekser B,et al.Impact of conversion to a once daily tacrolimus-based regimen in kidney transplant recipients with gastrointestinal complications[J].Transplantation,2012, 93(9):895-899.
[10]Jin J,Lim SW,Jin L,et al.Effects of metformin on hyperglycemia in an experimental model of tacrolimus-and sirolimus-induced diabetic rats[J].Korean J Intern Med,2017,32(2):314-322.
[11]Sivakumar V,Sriramnaveen P,Krishna C,et al.Role of fludrocortisone in the management of tacrolimus-induced hyperkalemia in a renal transplant recipient[J].Saudi J Kidney Dis Transpl,2014,25(1):149-151.
[12]Tricot L,Lebbé C,Pillebout E,et al.Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients[J].Transplantation,2005,80(11):1546-1549.
[13]Dhillon S,Kostrzewski A,editors.Clinical Pharmacokinetics[M].Aucklan:Pharmaceutical Press,2006:62-63.
[14]Yamaguchi J,Kasanuki H,Ishii Y,et al.Prognostic significance of serum creatinine concentration for in-hospital mortality in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention(from the Heart Institute of Japan Acute Myocardial Infarction[HIJAMI] Registry)[J].Am J Cardiol,2004,93(12):1526-1528.
[15]Lipinski M,Rydzewski A,Rydzewska G.Early changes in serum creatinine level and estimated glomerular filtration rate predict pancreatic necrosis and mortality in acute pancreatitis: Creatinine and eGFR in acute pancreatitis[J].Pancreatology,2013,13(3):207-211.
[16]Elsayed MG,Elkomy AA,Gaballah MS,et al.Nephrotoxicity of cefepime:A new cephalosporin antibiotic in rats[J].J Pharmacol Pharmacother,2014,5(1):33-38.
[17]Moresco RN,Bochi GV,Stein CS,et al.Urinary kidney injury molecule-1 in renal disease[J]. Clin Chim Acta,2018(487):15-21.
[18]Ba Aqeel SH,Sanchez A,Batlle D.Angiotensinogen as a biomarker of acute kidney injury[J].Clin Kidney J,2017,10(6):759-768.
[19]Lobato GR,Lobato MR,Thomé FS,et al.Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin,and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes[J].Braz J Med Biol Res,2017,50(5):e6106.
[20]Cho SY,Hur M.Neutrophil Gelatinase-Associated Lipocalin as a Promising Novel Biomarker for Early Detection of Kidney Injury[J].Ann Lab Med,2018,38(5):393-394.
[21]Choudhary A,Basu S,Dey SK,et al.Association and prognostic value of serum Cystatin C,IL-18 and Uric acid in urological patients with acute kidney injury[J].Clin Chim Acta,2018(482):144-148.
[22]Wunnpuk K,Liu X,Peake P,et al.Renal biomarkers predict nephrotoxicity after paraquat[J].Toxicol Lett,2013,222(3):280-288.
[23]van Timmeren MM,van den Heuvel MC,Bailly V,et al.Tubular kidney injury molecule-1(KIM-1) in human renal disease[J].J Pathol,2007,212(2):209-217.
[24]Hjortrup PB,Haase N,Treschow F,et al.Predictive value of NGAL for use of renal replacement therapy in patients with severe sepsis[J].Acta Anaesthesiol Scand,2015,59(1):25-34.
[25]Smertka M,Wroblewska J,Suchojad A,et al.Serum and urinary NGAL in septic newborns[J].Biomed Res Int,2014(2014):717318.
[26]Fleck C,Schweitzer F,Karge E,et al.Serum concentrations of asymmetric(ADMA)and symmetric (SDMA)dimethylarginine in patients with chronic kidney diseases[J].Clin Chim Acta,2003,336(1-2):1-12.
[27]Xia T,Fu S,Wang Q,et al.Targeted metabolomic analysis of 33 amino acids and biogenic amines in human urine by ion-pairing HPLC-MS/MS:Biomarkers for tacrolimus nephrotoxicity after renal transplantation[J].Biomed Chromatogr,2018,33(7):e4198.
[28]Saito K,Fujigaki S,HeyesMP,et al.Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency[J].Am J Physiol Renal Physiol,2000,279(3):F565-F572.
[29]Zhang F,Wang Q,Xia T,et al.Diagnostic value of plasma tryptophan and symmetric dimethylarginine levels for acute kidney injury among tacrolimus-treated kidney transplant patients by targeted metabolomics analysis[J].Sci Rep,2018,8(1):14688.